Compare Meihao Medical Group Co., Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
HKD 297 Million ()
NA (Loss Making)
NA
0.00%
-0.70
-12.97%
2.52
Revenue and Profits:
Net Sales:
22 Million
(Quarterly Results - Dec 2019)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.99%
0%
20.99%
6 Months
38.03%
0%
38.03%
1 Year
63.33%
0%
63.33%
2 Years
16.67%
0%
16.67%
3 Years
-1.01%
0%
-1.01%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Meihao Medical Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
16.63%
EBIT Growth (5y)
-68.38%
EBIT to Interest (avg)
-16.71
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.59
Sales to Capital Employed (avg)
10.37
Tax Ratio
12.59%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.55
EV to EBIT
-9.37
EV to EBITDA
-15.56
EV to Capital Employed
6.22
EV to Sales
1.97
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-66.36%
ROE (Latest)
-12.97%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
110.30
81.00
36.17%
Operating Profit (PBDIT) excl Other Income
-6.30
-20.20
68.81%
Interest
0.60
1.80
-66.67%
Exceptional Items
3.20
0.00
Consolidate Net Profit
-15.30
-35.40
56.78%
Operating Profit Margin (Excl OI)
-203.10%
-439.40%
23.63%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 36.17% vs -0.25% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 56.78% vs -136.00% in Dec 2024
About Meihao Medical Group Co., Ltd. 
Meihao Medical Group Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






